Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium benzoate adjunctive treatment for early psychosis
ACTRN12615000187549Phase 4Completed
- Sponsor
- The University of Queensland
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in psychosis, schizophrenia, schizophreniform disorder and 3 more comparing Sodium benzoate + routine care with Placebo + routine care (2 arms). Primary endpoint: Positive and Negative Syndrome Scale total score. Started Aug 2015; status: completed.
02
Drugs
sodium benzoate
03
Conditions
psychosisschizophreniaschizophreniform disorderdelusional disorderbipolar disorder (BD)
Beyond the preview
Go deeper on ACTRN12615000187549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000187549.